Huntington, K.E.; Carlsen, L.; So, E.-Y.; Piesche, M.; Liang, O.; El-Deiry, W.S.
Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity. Pharmaceuticals 2022, 15, 618.
https://doi.org/10.3390/ph15050618
AMA Style
Huntington KE, Carlsen L, So E-Y, Piesche M, Liang O, El-Deiry WS.
Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity. Pharmaceuticals. 2022; 15(5):618.
https://doi.org/10.3390/ph15050618
Chicago/Turabian Style
Huntington, Kelsey E., Lindsey Carlsen, Eui-Young So, Matthias Piesche, Olin Liang, and Wafik S. El-Deiry.
2022. "Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity" Pharmaceuticals 15, no. 5: 618.
https://doi.org/10.3390/ph15050618
APA Style
Huntington, K. E., Carlsen, L., So, E.-Y., Piesche, M., Liang, O., & El-Deiry, W. S.
(2022). Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity. Pharmaceuticals, 15(5), 618.
https://doi.org/10.3390/ph15050618